Suscribete

CRI Lanza Su Website Como Centro De Información En Español

En conmemoración del 9o aniversario del Mes de la Inmunoterapia contra el Cáncer, el CRI tiene como...

CRI Launches Spanish-Language Resource Hub

This 9th annual Cancer Immunotherapy Month™, CRI aims to help close the information and research gap to...

CRI Celebrates Diversity During 9th Cancer Immunotherapy Month in June

En junio, al celebrar el noveno Mes de la inmunoterapia, el Cancer Research Institute conmemora los avances...

CRI Celebrates Diversity During 9th Cancer Immunotherapy Month in June

Cancer Research Institute celebrates progress in cancer immunotherapy research, announces new initiatives aimed at addressing racial and ethnic...

CRI and RevImmune Announce Dosing of First Patient in New Phase 2 Study

Primer estudio en probar la IL-7 de RevImmune, un fármaco de interés médico, en pacientes con cáncer...

CRI and RevImmune Announce Dosing of First Patient in New Phase 2 Study

First study to test RevImmune’s IL-7 drug candidate in cancer patients infected with the SARS-CoV-2 coronavirus at...

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.